[Keratin fragments as a serological indicator in patients with a liver disease]

J Lata1, H Mrlianová, O Stibůrek

  • 1Interní klinika Lékarské fakulty Ostravské univerzity a FN Ostrava. Jan.Lata@osu.cz

Vnitrni Lekarstvi
|January 27, 2012
PubMed
Abstract

Insights

M30 antigen is a sensitive indicator of liver damage, showing significant differences between patients and healthy controls. It strongly correlates with liver enzymes (ALT, AST) and tissue polypeptide-specific antigen (TPS), suggesting TPS may also indicate liver apoptosis.

Area of Science:

  • Hepatology
  • Biochemistry
  • Clinical Diagnostics

Context:

  • Hepatocyte apoptosis evaluation is crucial for understanding liver disease progression.
  • M30 antigen is recognized as a sensitive marker for assessing liver cell apoptosis.

Purpose:

  • To implement M30 antigen assessment for hepatocyte apoptosis.
  • To compare M30 levels in liver disease patients versus healthy controls.
  • To explore correlations between M30 values and clinical/laboratory parameters.

Summary:

  • M30 antigen levels were significantly different between liver disease patients (n=25) and healthy controls (n=30).
  • Significant correlations were observed between M30 and ALT, AST, and tissue polypeptide-specific antigen (TPS).
  • M30 serves as a sensitive indicator of liver damage, with TPS potentially indicating apoptosis in certain liver conditions.

Impact:

  • Establishes M30 antigen as a valuable tool for quantifying hepatocyte apoptosis in clinical settings.
  • Highlights the potential of TPS as a surrogate marker for apoptosis in liver disease.
  • Provides insights into the relationship between apoptosis markers and liver injury severity.